MRI Texture Analysis for Differentiation of Malignant and Benign Hepatocellular Tumors in the Non-cirrhotic Liver
Overview
Authors
Affiliations
Purpose: To find potentially diagnostic texture analysis (TA) features and to evaluate the diagnostic accuracy of two-dimensional (2D) magnetic resonance (MR) TA for differentiation between hepatocellular carcinoma (HCC) and benign hepatocellular tumors in the non-cirrhotic liver in an exploratory MR-study.
Materials And Methods: 108 non-cirrhotic patients (62 female; 41.5 ± 18.3 years) undergoing preoperative contrast-enhanced MRI were retrospectively included in this multi-center-study. TA including gray-level histogram, co-occurrence and run-length matrix features (total 19 features) was performed by two independent readers. Native fat-saturated-T1w and T2w as well as arterial and portal-venous post contrast-enhanced 2D-image-slices were assessed. Conventional reading was performed by two separate independent readers. Differences in TA features between HCC and benign lesions were investigated using independent sample t-tests. Logistic regression analysis was performed to obtain the optimal number/combination of TA-features and diagnostic accuracy of TA analysis. Sensitivity and specificity of the better performing radiologist were compared to TA analysis.
Results: The highest number of significantly differing TA-features (n = 5) was found using the arterial-phase images including one gray-level histogram (skewness, p = 0.018) and four run-length matrix features (all, p < 0.02). The optimal binary logistic regression model for TA-features of the arterial-phase images contained 13 parameters with an accuracy of 84.5% (sensitivity 84.1%, specificity 84.9%) and area-under-the-curve of 0.92 (95%-confidence-interval 0.85-0.98) for diagnosis of HCC. Conventional reading yielded a significantly lower sensitivity (63.6%, p = 0.027) and no significant difference in specificity (94.6%, p = 0.289) at best.
Conclusion: 2D-TA of MR images is a feasible objective method that may help to distinguish HCC from benign hepatocellular tumors in the non-cirrhotic liver. Most promising results were found in TA features in the arterial phase images.
Salahshour F, Ghamari Khameneh A, Darban Hosseini Amirkhiz G, Ayoobi Yazdi N, Shafiekhani S Pol J Radiol. 2024; 88:e589-e596.
PMID: 38362015 PMC: 10867978. DOI: 10.5114/pjr.2023.134043.
Brancato V, Cerrone M, Garbino N, Salvatore M, Cavaliere C World J Gastroenterol. 2024; 30(4):381-417.
PMID: 38313230 PMC: 10835534. DOI: 10.3748/wjg.v30.i4.381.
Abdullah A, Amanpour-Gharaei B, Toosi M, Delazar S, Saligheh Rad H, Arian A Cureus. 2024; 16(1):e51443.
PMID: 38298321 PMC: 10829059. DOI: 10.7759/cureus.51443.
Focal Lesions of the Liver and Radiomics: What Do We Know?.
Anichini M, Galluzzo A, Danti G, Grazzini G, Pradella S, Treballi F Diagnostics (Basel). 2023; 13(15).
PMID: 37568954 PMC: 10417608. DOI: 10.3390/diagnostics13152591.
Arian A, Abdullah A, Taher H, Suhail Alareer H, Fotouhi M Cureus. 2023; 15(3):e36082.
PMID: 37065286 PMC: 10097431. DOI: 10.7759/cureus.36082.